SRPT FY 2015 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SRPTSarepta Therapeutics, Inc.

$2B

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M-87.2% YoY

Gross Profit

-$145M-11567.5% margin

Operating Income

-$220M-17572.5% margin

Net Income

-$220M-17560.3% margin

EPS (Diluted)

$-5.20

Cash Flow

Operating Cash Flow

-$149M

Free Cash Flow

-$154M

Stock-Based Comp.

$32M

Balance Sheet

Total Assets

$274M

Total Liabilities

$83M

Stockholders' Equity

$190M

Cash & Equivalents

$80M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$10M	-87.2%
Gross Profit	-$145M	-$84M	-71.8%
Operating Income	-$220M	-$134M	-64.6%
Net Income	-$220M	-$136M	-62.0%